SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
- DOI
- 10.1038/s41564-021-00954-4
- Published
- 2021 Sep
- Container
- Nature microbiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41564-021-00954-4,
title = {SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.},
author = {Zahradník J and Marciano S and Shemesh M and Zoler E and Harari D and Chiaravalli J and Meyer B and Rudich Y and Li C and Marton I and Dym O and Elad N and Lewis MG and Andersen H and Gagne M and Seder RA and Douek DC and Schreiber G},
year = {2021},
journal = {Nature microbiology},
doi = {10.1038/s41564-021-00954-4},
url = {https://doi.org/10.1038/s41564-021-00954-4}
}RIS
TY - JOUR TI - SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. AU - Zahradník J AU - Marciano S AU - Shemesh M AU - Zoler E AU - Harari D AU - Chiaravalli J AU - Meyer B AU - Rudich Y AU - Li C AU - Marton I AU - Dym O AU - Elad N AU - Lewis MG AU - Andersen H AU - Gagne M AU - Seder RA AU - Douek DC AU - Schreiber G PY - 2021 JO - Nature microbiology DO - 10.1038/s41564-021-00954-4 UR - https://doi.org/10.1038/s41564-021-00954-4 ER -
APA
J, Z., S, M., M, S., E, Z., D, H., J, C., B, M., Y, R., C, L., I, M., O, D., N, E., MG, L., H, A., M, G., RA, S., DC, D., & G, S. (2021). SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.. Nature microbiology. https://doi.org/10.1038/s41564-021-00954-4
Source records
- pubmed · retrieved 2026-09-25T16:49:47.245Z